VCAM1 and neoplasm: To this end, using an MRI contrast agent based on microparticles of iron oxide (MPIO) and targeted to VCAM-1, we have previously demonstrated that VCAM-1 provides a sensitive and specific endothelial biomarker of early brain metastasis [14,15], as well as improving detection of the tumour-brain interface [21].